• Department of Thoracic Surgery I, Cancer Hospital &;
  • Institute, Peking University, Key Laboratory of Carcinogenesis and Translational Research of Ministry of Education, Beijing 100142, P. R. China;
Export PDF Favorites Scan Get Citation

Abstract: Sarcoidosis is a common systemic disease with noncaseating granulomatous epithelioid nodule and coexisting granulomatous inflammation. Although sarcoidosis can affect any organ of the body, more than 90% of the patients demonstrate thoracic involvement, which is often confusing with lung cancer and other diseases. Therefore, thoracic surgeons must have a clear understanding of sarcoidosis. Moreover, due to the special role of surgery in obtaining pathological specimens, thoracic surgeon plays an important role in the diagnosis and treatment of sarcoidosis. It is not difficult to make diagnosis for patients with typical clinical features of sarcoidosis. However, the majority of patients do not have specific manifestations of sarcoidosis. The cause of sarcoidosis remains unknown, and there is also no specific treatment strategy for it. But recent research has shown that annexin A11 gene may be involved in the pathogenesis of sarcoidosis, and tumor necrosis factor (TNF) inhibitor is effective in the treatwent of sarcoidosis.

Citation: YANG Heli,CHEN Keneng.. Sarcoidosis-A Disease Needs to Be Differentiated from Lung Cancer. Chinese Journal of Clinical Thoracic and Cardiovascular Surgery, 2012, 19(6): 663-667. doi: Copy